Literature DB >> 15117561

Natural honey lowers plasma glucose, C-reactive protein, homocysteine, and blood lipids in healthy, diabetic, and hyperlipidemic subjects: comparison with dextrose and sucrose.

Noori S Al-Waili1.   

Abstract

This study included the following experiments: (1) effects of dextrose solution (250 mL of water containing 75 g of dextrose) or honey solution (250 mL of water containing 75 g of natural honey) on plasma glucose level (PGL), plasma insulin, and plasma C-peptide (eight subjects); (2) effects of dextrose, honey, or artificial honey (250 mL of water containing 35 g of dextrose and 40 g of fructose) on cholesterol and triglycerides (TG) (nine subjects); (3) effects of honey solution, administered for 15 days, on PGL, blood lipids, C-reactive protein (CRP), and homocysteine (eight subjects); (4) effects of honey or artificial honey on cholesterol and TG in six patients with hypercholesterolemia and five patients with hypertriglyceridemia; (5) effects of honey for 15 days on blood lipid and CRP in five patients with elevated cholesterol and CRP; (6) effects of 70 g of dextrose or 90 g of honey on PGL in seven patients with type 2 diabetes mellitus; and (7) effects of 30 g of sucrose or 30 g of honey on PGL, plasma insulin, and plasma C-peptide in five diabetic patients. In healthy subjects, dextrose elevated PGL at 1 (53%) and 2 (3%) hours, and decreased PGL after 3 hours (20%). Honey elevated PGL after 1 hour (14%) and decreased it after 3 hours (10%). Elevation of insulin and C-peptide was significantly higher after dextrose than after honey. Dextrose slightly reduced cholesterol and low-density lipoprotein-cholesterol (LDL-C) after 1 hour and significantly after 2 hours, and increased TG after 1, 2, and 3 hours. Artificial honey slightly decreased cholesterol and LDL-C and elevated TG. Honey reduced cholesterol, LDL-C, and TG and slightly elevated high-density lipoprotein-cholesterol (HDL-C). Honey consumed for 15 days decreased cholesterol (7%), LDL-C (1%), TG (2%), CRP (7%), homocysteine (6%), and PGL (6%), and increased HDL-C (2%). In patients with hypertriglyceridemia, artificial honey increased TG, while honey decreased TG. In patients with hyperlipidemia, artificial honey increased LDL-C, while honey decreased LDL-C. Honey decreased cholesterol (8%), LDL-C (11%), and CRP (75%) after 15 days. In diabetic patients, honey compared with dextrose caused a significantly lower rise of PGL. Elevation of PGL was greater after honey than after sucrose at 30 minutes, and was lower after honey than it was after sucrose at 60, 120, and 180 minutes. Honey caused greater elevation of insulin than sucrose did after 30, 120, and 180 minutes. Honey reduces blood lipids, homocysteine, and CRP in normal and hyperlipidemic subjects. Honey compared with dextrose and sucrose caused lower elevation of PGL in diabetics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117561     DOI: 10.1089/109662004322984789

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  45 in total

1.  Effects of honey on the urinary total nitrite and prostaglandins concentration.

Authors:  Noori S Al-Waili
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

2.  Zero flow global ischemia-induced injuries in rat heart are attenuated by natural honey.

Authors:  Moslem Najafi; Fahimeh Zahednezhad; Mehrban Samadzadeh; Haleh Vaez
Journal:  Adv Pharm Bull       Date:  2012-06-25

3.  The effect of a cinnamon-, chromium- and magnesium-formulated honey on glycaemic control, weight loss and lipid parameters in type 2 diabetes: an open-label cross-over randomised controlled trial.

Authors:  Patricia Whitfield; Amber Parry-Strong; Emily Walsh; Mark Weatherall; Jeremy D Krebs
Journal:  Eur J Nutr       Date:  2015-05-19       Impact factor: 5.614

Review 4.  Novel Insights into the Health Importance of Natural Honey.

Authors:  Abdulwahid Ajibola
Journal:  Malays J Med Sci       Date:  2015-09

5.  Honey does not adversely impact blood lipids of adult men and women: a randomized cross-over trial.

Authors:  Alia Mb Al-Tamimi; Mayumi Petrisko; Mee Young Hong; Lauren Rezende; Zachary S Clayton; Mark Kern
Journal:  Nutr Res       Date:  2019-11-30       Impact factor: 3.315

6.  Adverse effects of honey on low-density lipoprotein cholesterol and adiponectin concentrations in patients with type 2 diabetes: a randomized controlled cross-over trial.

Authors:  Fatemeh Sadeghi; Masoumeh Akhlaghi; Saedeh Salehi
Journal:  J Diabetes Metab Disord       Date:  2020-04-14

7.  Nutraceutical values of natural honey and its contribution to human health and wealth.

Authors:  Abdulwahid Ajibola; Joseph P Chamunorwa; Kennedy H Erlwanger
Journal:  Nutr Metab (Lond)       Date:  2012-06-20       Impact factor: 4.169

8.  Traditional and modern uses of natural honey in human diseases: a review.

Authors:  Tahereh Eteraf-Oskouei; Moslem Najafi
Journal:  Iran J Basic Med Sci       Date:  2013-06       Impact factor: 2.699

Review 9.  Honey--a novel antidiabetic agent.

Authors:  Omotayo O Erejuwa; Siti A Sulaiman; Mohd S Ab Wahab
Journal:  Int J Biol Sci       Date:  2012-07-07       Impact factor: 6.580

10.  Intravenous administration of manuka honey inhibits tumor growth and improves host survival when used in combination with chemotherapy in a melanoma mouse model.

Authors:  Maria J Fernandez-Cabezudo; Rkia El-Kharrag; Fawaz Torab; Ghada Bashir; Junu A George; Hakam El-Taji; Basel K al-Ramadi
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.